Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ELREXFIO SPECIAL INVESTIGATION- INVESTIGATION ON LONG-TERM TREATMENT -

NCT06479954 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT06479954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06479954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ELREXFIO SPECIAL INVESTIGATION- INVESTIGATION ON LONG-TERM TREATMENT -
Lead sponsor
Pfizer
Phase
Observational
Overall status
Active, not recruiting
Start date
July 30, 2024
Completion date
February 25, 2027
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed and refractory multiple myeloma (rrmm)